- Instagram: @item_9_labs
- Website: item9labs.com
Item 9 Labs – Phoenix, AZ
Item 9 Labs hasn’t been around long, but they’re already expanding their 10,000-square-foot facilitylocated on unused farmland south of Phoenix, Arizona, just past a chute of feeding cows. Led by co-founders Bryce Skalla, Mark Murro and Andrew Poirier, the company plans to construct a 20,000-square-foot building next to their existing facility, with one goal in mind: increase product availability. Beginning with 100 strains when their grow officially opened on April 20, 2017, they’ve whittled that number down to 40 varieties, with plans to go even lower as they discover what their patients respond to, as well as what grows best. “Our concentrates and distillates grew so much [in volume], we outgrew our lab and packaging. It’s a tedious process. These guys will bust out thousands of cartridges,” notes director of sales Michael Willis.
Their current facility houses multiple grow rooms, a nursery, a few shipping containers turned climate-controlled cure areas, and an extraction lab, as well as compliance and trim teams. They won’t get much relief, space-wise, in the near future, as their upcoming 20,000-square-foot building will be almost entirely devoted to growing flower. They have plans for a 30,000-square-foot greenhouse that will house a full edibles kitchen and allow development of their own genetics, but that’s still a couple of years away.“We’re trying to dial in what’s going on, then we’ll move on,” says lead grower Chaz Apostle, referencing the company’s eye on expansion.
Item 9 Labs plans on nearly doubling their current staff of 31 members as they continue to grow. Goals include increasing flower production and distribution from their current four dispensary groups to better match their concentrates’ availability in more than 30shops. They’ll also have their Apollo 710 POD system fully available by fall, featuring steam-distilled terpenes, live resin and D8- and D9-THC blends. In addition, look for their flagship Delta–8–THC to soon be available in capsules and syringes, for easier consumption.